Bath & Body Works (NYSE:BBWI – Get Free Report) is one of 27 public companies in the “Retail stores, not elsewhere classified” industry, but how does it weigh in compared to its competitors? We will compare Bath & Body Works to similar businesses based on the strength of its earnings, risk, valuation, institutional ownership, profitability, analyst recommendations and dividends.
Analyst Recommendations
This is a breakdown of recent recommendations and price targets for Bath & Body Works and its competitors, as provided by MarketBeat.
Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
Bath & Body Works | 1 | 6 | 9 | 0 | 2.50 |
Bath & Body Works Competitors | 95 | 875 | 1511 | 62 | 2.61 |
Bath & Body Works currently has a consensus target price of $42.50, indicating a potential upside of 9.99%. As a group, “Retail stores, not elsewhere classified” companies have a potential upside of 8.99%. Given Bath & Body Works’ higher possible upside, equities research analysts clearly believe Bath & Body Works is more favorable than its competitors.
Insider and Institutional Ownership
Volatility and Risk
Bath & Body Works has a beta of 1.83, suggesting that its share price is 83% more volatile than the S&P 500. Comparatively, Bath & Body Works’ competitors have a beta of 0.89, suggesting that their average share price is 11% less volatile than the S&P 500.
Dividends
Bath & Body Works pays an annual dividend of $0.80 per share and has a dividend yield of 2.1%. Bath & Body Works pays out 19.5% of its earnings in the form of a dividend. As a group, “Retail stores, not elsewhere classified” companies pay a dividend yield of 2.6% and pay out 28.5% of their earnings in the form of a dividend.
Profitability
This table compares Bath & Body Works and its competitors’ net margins, return on equity and return on assets.
Net Margins | Return on Equity | Return on Assets | |
Bath & Body Works | 12.43% | -44.03% | 14.45% |
Bath & Body Works Competitors | -21.34% | -60.07% | 0.73% |
Valuation and Earnings
This table compares Bath & Body Works and its competitors revenue, earnings per share (EPS) and valuation.
Gross Revenue | Net Income | Price/Earnings Ratio | |
Bath & Body Works | $7.43 billion | $878.00 million | 9.42 |
Bath & Body Works Competitors | $48.40 billion | $153.49 million | -5.57 |
Bath & Body Works’ competitors have higher revenue, but lower earnings than Bath & Body Works. Bath & Body Works is trading at a higher price-to-earnings ratio than its competitors, indicating that it is currently more expensive than other companies in its industry.
Summary
Bath & Body Works beats its competitors on 9 of the 15 factors compared.
About Bath & Body Works
Bath & Body Works, Inc. operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products. It sells its products under the Bath & Body Works, White Barn, and other brand names through retail stores and e-commerce sites located in the United States and Canada, as well as through international stores operated by partners under franchise, license, and wholesale arrangements. The company was formerly known as L Brands, Inc. and changed its name to Bath & Body Works, Inc. in August 2021. Bath & Body Works, Inc. was founded in 1963 and is headquartered in Columbus, Ohio.
Receive News & Ratings for Bath & Body Works Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bath & Body Works and related companies with MarketBeat.com's FREE daily email newsletter.